Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in Man
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Fifteen patients in whom various parts of the small intestine had been resected because of Crohn's disease or mesenteric thrombosis and 10 healthy volunteers were studied. A 50-g oral glucose load (OGTT) and an intravenous glucose infusion giving the same plasma glucose profile as the OGTT were carried out to study (a) the relation between the plasma gastric inhibitory polypeptide (GIP) levels after oral glucose and the length and nature of the intestinal residues and (b) the importance of endogenous GIP as an incretin in man. The magnitude of the increase in plasma GIP after oral glucose load was positively correlated to the length of residual jejunum. The incretin effect was positively correlated to the length of residual intestine. Patients with preserved ileal residues had larger incretin effects than patients with less than 150 cm jejunal residues and no ileal residues, although the integrated increases in plasma GIP after oral glucose were equal. Compared with healthy volunteers, the patients with more than 150 cm residual jejunum had significantly higher increases in plasma GIP and normal incretin effects. The GIP release and the incretin effect in patients with preserved ileal residues were normal. The incretin effect of the patients with less than 150 cm jejunum was significantly subnormal in spite of a normal GIP release. These findings indicate that the upper intestine releases GIP after oral glucose and that other as yet unknown intestinal hormonal factors act as…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies further revealed that chemogenetic activation of GIPR neurons in either the hypothalamus or the hindbrain reduces food intake42,43 (Figure 1)”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [43]
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Nonparametric statistics for the behavioral sciences
McGinn, L. C. (1957) · Journal of the Franklin Institute · doi:10.1016/0016-0032(57)90766-4 · Cited by 7,204
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 883
STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN. 1
Dupre, J., Ross, S. A., Watson, D., & Brown, J. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-826 · Cited by 860
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Gastric Inhibitory Polypeptide (GIP) Stimulation by Oral Glucose in Man
CATALAND, S., CROCKETT, S. E., BROWN, J. C., & MAZZAFERRI, E. L. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-223 · Cited by 227
The Insulinotropic Action of Gastric Inhibitory Polypeptide in the Perfused Isolated Rat Pancreas
PEDERSON, R. A., & BROWN, J. C. (1976) · Endocrinology · doi:10.1210/endo-99-3-780 · Cited by 209
Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum
Polak, J. M., Bloom, S. R., Kuzio, M., Brown, J. C., & Pearse, A. G. E. (1973) · Gut · doi:10.1136/gut.14.4.284 · Cited by 166
Research works printed but not linked: 2
- Brown, J. C. & Pederson, R. A. pp. 568–570 in Endocrinology. Proceedings of the Vth International Congress of Endocrinology, Vol. 2. Excerpta Medica, Amsterdam, 1977
- Zunz E., 1929, Arch. Int. Physiol., 57, 20
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“Studies in humans with resection of different parts of the small intestine demonstrated that the incretin effect and the GIP response to oral glucose did not correlate e the incretin effect was better correlated with preservation of the ileum [79].”
BackgroundKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
Holst, J. J., Ørskov, C., Vagn Nielsen, O., & Schwartz, T. W. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81430-8 · Cited by 615
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
Holst, J. J., & Gromada, J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00545.2003 · Cited by 611
“The distal small intestine, therefore, had to release an additional incretin hormone (42).”
Background
Metadata
- Authors
- Lauritsen, K. B., Moody, A. J., Christensen, K. C., & Lindkár Jensen, S.
- Affiliations
- Hvidovre Hospital (DK)
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 1980-10
- Volume
- 15
- Issue
- 7
- Pages
- 833-840
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2122946361
- Cited by
- 77
- References
- 18
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 3 · 2019: 4 · 2018: 2 · 2016: 3 · 2015: 1 · 2013: 2 · 2012: 3
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- glucose-dependent insulinotropic polypeptide, incretins, insulin secretion, small bowel resection, oral glucose tolerance, Crohn's disease, mesenteric thrombosis, intestinal hormones, glucose-stimulated insulin secretion
- MeSH terms
- Adult, Blood Glucose, Crohn Disease, Female, Gastric Inhibitory Polypeptide, Gastrointestinal Hormones, Glucose Tolerance Test, Humans, Insulin, Intestine, Small, Male, Mesenteric Vascular Occlusion, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in Man. https://app.cochat.ai/papers/10.3109/00365528009181538
- The paper
- Lauritsen, K. B., Moody, A. J., Christensen, K. C., & Lindkár Jensen, S. (1980). Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in Man. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365528009181538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.